180 related articles for article (PubMed ID: 19837728)
1. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women.
Fairley CK; Hocking JS; Gurrin LC; Chen MY; Donovan B; Bradshaw CS
Sex Transm Infect; 2009 Dec; 85(7):499-502. PubMed ID: 19837728
[TBL] [Abstract][Full Text] [Related]
2. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme.
Chow EP; Read TR; Wigan R; Donovan B; Chen MY; Bradshaw CS; Fairley CK
Sex Transm Infect; 2015 May; 91(3):214-9. PubMed ID: 25305210
[TBL] [Abstract][Full Text] [Related]
3. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK
Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976
[TBL] [Abstract][Full Text] [Related]
4. Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004-18.
Chow EPF; Carter A; Vickers T; Fairley CK; McNulty A; Guy RJ; Regan DG; Grulich AE; Callander D; Khawar L; Machalek DA; Donovan B
Lancet Infect Dis; 2021 Dec; 21(12):1747-1756. PubMed ID: 34339639
[TBL] [Abstract][Full Text] [Related]
5. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
Oliphant J; Perkins N
N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330
[TBL] [Abstract][Full Text] [Related]
6. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme.
Read TR; Hocking JS; Chen MY; Donovan B; Bradshaw CS; Fairley CK
Sex Transm Infect; 2011 Dec; 87(7):544-7. PubMed ID: 21970896
[TBL] [Abstract][Full Text] [Related]
7. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
Ali H; Donovan B; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Guy RJ
BMJ; 2013 Apr; 346():f2032. PubMed ID: 23599298
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data.
Ali H; McManus H; O'Connor CC; Callander D; Kong M; Graham S; Saulo D; Fairley CK; Regan DG; Grulich A; Low N; Guy RJ; Donovan B
Med J Aust; 2017 Mar; 206(5):204-209. PubMed ID: 28301790
[TBL] [Abstract][Full Text] [Related]
9. Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis.
Canvin M; Sinka K; Hughes G; Mesher D
Sex Transm Infect; 2017 Mar; 93(2):125-128. PubMed ID: 27365492
[TBL] [Abstract][Full Text] [Related]
10. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
Chow EPF; Machalek DA; Tabrizi SN; Danielewski JA; Fehler G; Bradshaw CS; Garland SM; Chen MY; Fairley CK
Lancet Infect Dis; 2017 Jan; 17(1):68-77. PubMed ID: 27282422
[TBL] [Abstract][Full Text] [Related]
11. Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017.
Checchi M; Mesher D; Mohammed H; Soldan K
Sex Transm Infect; 2019 Aug; 95(5):368-373. PubMed ID: 30723186
[TBL] [Abstract][Full Text] [Related]
12. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
Lurie S; Mizrachi Y; Chodick G; Katz R; Schejter E
Gynecol Oncol; 2017 Aug; 146(2):299-304. PubMed ID: 28602548
[TBL] [Abstract][Full Text] [Related]
13. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program.
Ali H; Guy RJ; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Donovan B
BMC Infect Dis; 2013 Mar; 13():140. PubMed ID: 23506489
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J
Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554
[TBL] [Abstract][Full Text] [Related]
15. The incidence of genital warts in Australian women prior to the national vaccination program.
Brotherton JM; Heywood A; Heley S
Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
[TBL] [Abstract][Full Text] [Related]
16. Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males.
Korostil IA; Ali H; Guy RJ; Donovan B; Law MG; Regan DG
Sex Transm Dis; 2013 Nov; 40(11):833-5. PubMed ID: 24113401
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study.
Dominiak-Felden G; Gobbo C; Simondon F
PLoS One; 2015; 10(7):e0132404. PubMed ID: 26147096
[TBL] [Abstract][Full Text] [Related]
18. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program.
Baandrup L; Blomberg M; Dehlendorff C; Sand C; Andersen KK; Kjaer SK
Sex Transm Dis; 2013 Feb; 40(2):130-5. PubMed ID: 23324976
[TBL] [Abstract][Full Text] [Related]
19. The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity.
Orumaa M; Kjaer SK; Dehlendorff C; Munk C; Olsen AO; Hansen BT; Campbell S; Nygård M
Vaccine; 2020 Feb; 38(6):1345-1351. PubMed ID: 31917039
[TBL] [Abstract][Full Text] [Related]
20. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis.
Denecke A; Iftner T; Iftner A; Riedle S; Ocak M; Luyten A; Üye I; Tunc K; Petry KU
BMC Infect Dis; 2021 Jul; 21(1):634. PubMed ID: 34215215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]